✉ Email this page to a colleague
« Back to Dashboard
Putrescine is an investigational drug.
There have been 7 clinical trials for Putrescine. The most recent clinical trial was a Phase 3 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Prostatic Neoplasms, Hemorrhage, and Periodontitis. The leading clinical trial sponsors are National Cancer Institute (NCI), University Hospital, Bordeaux, and Food and Drug Administration (FDA).
There are one hundred and ninety-one US patents protecting this investigational drug and twenty-seven international patents.
Recent Clinical Trials for Putrescine
|Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis||BioGaia AB||Phase 4|
|Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis||University of Zagreb||Phase 4|
|Feasibility Study on Stem Cells Sensitivity Assay||Associazione Oncologia Traslazionale||Phase 2|
Top disease conditions for Putrescine
Top clinical trial sponsors for Putrescine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Putrescine||See Plans and Pricing||Acylated amine compounds which are useful fungicigal agents||Roussel Uclaf (Paris, FR)||See Plans and Pricing|
|Putrescine||See Plans and Pricing||Liquid developer for electrostatic photography||Fuji Photo Film Co., Ltd. (Kanagawa, JP)||See Plans and Pricing|
|Putrescine||See Plans and Pricing||Process for producing unsaturated mono and dicarboxylic acid imide compound||Matsushita Electric Works Ltd. (Osaka, JP)||See Plans and Pricing|
|Putrescine||See Plans and Pricing||Cyclic hydrocarbons with an aminoalkyl sidechain||The Upjohn Company (Kalamazoo, MI)||See Plans and Pricing|
|Putrescine||See Plans and Pricing||Composite dental cement composition containing a lanthanide series compound||Essential Dental Systems, Inc. (South Hackensack, NJ)||See Plans and Pricing|
|Putrescine||See Plans and Pricing||Dipyridoxyl phosphate chelating compound intermediates useful as NMRI contrast agents||Salutar, Inc. (Sunnyvale, CA)||See Plans and Pricing|
|Putrescine||See Plans and Pricing||Thermosetting polyurethane structural adhesive compositions and processes for producing the same||Rheox, Inc. (Hightstown, NJ)||See Plans and Pricing|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Putrescine||Canada||CA1268332||2006-10-23||See Plans and Pricing|
|Putrescine||Canada||CA1328060||2006-10-23||See Plans and Pricing|
|Putrescine||Germany||DE3786255||2006-10-23||See Plans and Pricing|
|Putrescine||Germany||DE3854011||2006-10-23||See Plans and Pricing|
|Putrescine||Germany||DE3855935||2006-10-23||See Plans and Pricing|
|Putrescine||European Patent Office||EP0283048||2006-10-23||See Plans and Pricing|
|Putrescine||European Patent Office||EP0288568||2006-10-23||See Plans and Pricing|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|